1. Home
  2. RXT vs DBVT Comparison

RXT vs DBVT Comparison

Compare RXT & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$4.70

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$18.41

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXT
DBVT
Founded
1998
2002
Country
United States
France
Employees
N/A
161
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
RXT
DBVT
Price
$4.70
$18.41
Analyst Decision
Hold
Buy
Analyst Count
6
7
Target Price
$1.71
$32.04
AVG Volume (30 Days)
27.8M
174.2K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
75.13
10.26
EPS
0.03
N/A
Revenue
$2,685,700,000.00
$5,636,000.00
Revenue This Year
N/A
$35.04
Revenue Next Year
$1.35
$2,360.78
P/E Ratio
$160.83
N/A
Revenue Growth
N/A
35.77
52 Week Low
$0.39
$7.53
52 Week High
$7.65
$26.19

Technical Indicators

Market Signals
Indicator
RXT
DBVT
Relative Strength Index (RSI) 58.18 37.63
Support Level $1.04 $16.49
Resistance Level N/A $21.61
Average True Range (ATR) 1.03 0.83
MACD 0.19 -0.13
Stochastic Oscillator 52.57 3.10

Price Performance

Historical Comparison
RXT
DBVT

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: